3T Biosciences

3T Biosciences is a South San Francisco-based immunotherapy company dedicated to developing next-generation therapies for solid tumors and other immune-mediated diseases. They leverage their proprietary 3T-TRACE platform, which combines high-diversity target libraries with active machine learning, to identify novel and highly immunogenic targets within solid tumors. This approach focuses on understanding how the immune system responds to cancer and utilizing that information to develop safer and more effective treatments for patients.

Their platform technology addresses key challenges in current immunotherapy development by identifying novel targets and comprehensively screening T cell receptors (TCRs) and TCR mimetics (TCRms) for specificity and cross-reactivity. This ensures the development of tumor-specific therapies that can be delivered at higher doses. 3T Biosciences is backed by top-tier investors including Westlake Village BioPartners, Lightspeed Venture Partners, and the Parker Institute for Cancer Immunotherapy. They are committed to bringing innovative therapies to patients in need and have established partnerships with leading academic institutions to further accelerate their research efforts.

3T Biosciences values work-life balance and supports career growth, flexibility, and opportunities for employees to learn new skills. They encourage a supportive and collaborative work environment where colleagues feel empowered to contribute their best work. This includes opportunities to explore different fields, build new skill sets, and apply those skills to foster innovation and accelerate research and therapeutic development.

3T Biosciences offers a generous benefits package that prioritizes the health and well-being of its employees and their families. This includes comprehensive health insurance covering medical, dental, and vision, flexible spending accounts, life and disability insurance, a 401(k) retirement savings plan, and generous paid time off. The company also offers company-paid holidays, equity participation, and flexible work arrangements to foster a positive work-life balance.

3T Biosciences is an immunotherapy company focused on developing next-generation therapies for the treatment of solid tumors and other immune-mediated diseases in broad patient populations. Their proprietary 3T-TRACETM platform technology revolutionizes target discovery and therapeutic development by identifying and validating T cell receptor (TCR) targets and specificities. Through this process, 3T strives to create therapies that are highly specific, safer, and more effective for patients in need of new treatment options.

3T Biosciences promotes a culture built on three pillars: tact, transparency, and trust. These pillars are essential for empowering employees to work harmoniously together, encourage career growth and flexibility, and foster innovation within the company. The company encourages colleagues to build relationships on both a professional and personal level, and to understand how their individual roles contribute to the larger goals of the company. The company also values diversity, equity, and inclusion, believing that a diverse and inclusive team is crucial for success.

3T Biosciences values a diverse and inclusive team, believing that a variety of perspectives are crucial to their success. They prioritize equity in their workplace by empowering each colleague, encouraging career growth, flexibility, and learning new skills. This fosters innovation and accelerates their research and therapeutic development.